Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANVAS-R renal outcomes study of canagliflozin in adults with type 2 diabetes mellitus
NL-OMON45079Phase 4Active, not recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Canagliflozin with Placebo (2 arms). Primary endpoint: Progression of albuminuria. Started Apr 2014; status: active, not recruiting.
02
Drugs
canagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON45079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45079.